MAPT and Alzheimer disease: The detection and progression of AD is frequently quantified using the ATN framework, which balances the contributions of three major axes of neuropathology: amyloid beta (Aβ) plaques (A), tau tangles (T), and neurodegeneration (N),3 each of which can be measured peripherally in the cerebrospinal fluid (CSF).4